These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 36949963)
21. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966 [TBL] [Abstract][Full Text] [Related]
22. Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants. Filipiak W; Ruzsanyi V; Mochalski P; Filipiak A; Bajtarevic A; Ager C; Denz H; Hilbe W; Jamnig H; Hackl M; Dzien A; Amann A J Breath Res; 2012 Sep; 6(3):036008. PubMed ID: 22932429 [TBL] [Abstract][Full Text] [Related]
23. Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients. van Oort PM; de Bruin S; Weda H; Knobel HH; Schultz MJ; Bos LD; On Behalf Of The Mars Consortium Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218729 [TBL] [Abstract][Full Text] [Related]
24. Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study. Pabst F; Miekisch W; Fuchs P; Kischkel S; Schubert JK J Cardiothorac Surg; 2007 Sep; 2():37. PubMed ID: 17877828 [TBL] [Abstract][Full Text] [Related]
25. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437 [TBL] [Abstract][Full Text] [Related]
26. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls. Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137 [TBL] [Abstract][Full Text] [Related]
27. Development and validation of a point-of-care breath test for octane detection. Hagens LA; Verschueren ARM; Lammers A; Heijnen NFL; Smit MR; Nijsen TME; Geven I; Schultz MJ; Bergmans DCJJ; Schnabel RM; Bos LDJ Analyst; 2021 Jul; 146(14):4605-4614. PubMed ID: 34160491 [TBL] [Abstract][Full Text] [Related]
28. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma. Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255 [TBL] [Abstract][Full Text] [Related]
30. Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research. Janssens E; Mol Z; Vandermeersch L; Lagniau S; Vermaelen KY; van Meerbeeck JP; Walgraeve C; Marcq E; Lamote K Front Oncol; 2022; 12():851785. PubMed ID: 35600344 [TBL] [Abstract][Full Text] [Related]
31. Exposure to volatile organic compounds may be associated with oxidative DNA damage-mediated childhood asthma. Kuang H; Li Z; Lv X; Wu P; Tan J; Wu Q; Li Y; Jiang W; Pang Q; Wang Y; Fan R Ecotoxicol Environ Saf; 2021 Mar; 210():111864. PubMed ID: 33412282 [TBL] [Abstract][Full Text] [Related]
32. Breath biomarkers of total body irradiation in non-human primates. Phillips M; Grun F; Schmitt P J Breath Res; 2022 Jan; 16(2):. PubMed ID: 34781275 [No Abstract] [Full Text] [Related]
33. Volatile metabolites differentiate air-liquid interface cultures after infection with Ahmed W; Bardin E; Davis MD; Sermet-Gaudelus I; Grassin Delyle S; Fowler SJ Analyst; 2023 Jan; 148(3):618-627. PubMed ID: 36597770 [TBL] [Abstract][Full Text] [Related]
34. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection. Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857 [No Abstract] [Full Text] [Related]
35. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102 [TBL] [Abstract][Full Text] [Related]
36. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air. Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the effect of chemically and biologically induced inflammation on the volatile metabolite production of lung epithelial cells by GC×GC-TOFMS. Zanella D; Henket M; Schleich F; Dejong T; Louis R; Focant JF; Stefanuto PH Analyst; 2020 Aug; 145(15):5148-5157. PubMed ID: 32633741 [TBL] [Abstract][Full Text] [Related]